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1 Introduction
Alpha-fetoprotein (AFP), a protein of fetal ori-
gin encountered in pregnancy serum, cord
serum and amniotic fluid, has been largely used
in prenatal diagnosis of open neural tube de-
fects and other fetal abnormalities by its quanti-
tation in maternal blood and amniotic fluid [2,
3]. High levels of AFP are also associated with
fetal distress and missed abortion [11, 12]. This
makes AFP measurement another potentially
useful tool to the study and management of
complicated pregnancies. There is a great varia-
bility of AFP values in maternal circulation at
the different periods of gestation taken sepa-
rately. This variability may be due to a number
of factors. Some of these factors were described
by HABIB [6], but in the whole they are not well
investigated. The present report attempts to
study the variation of the levels of AFP in
pregnancy serum with some obstetric land-
marks, in the hopes that part of this variability
could be clarified.
2 Material and methods
Peripheral venous blood samples were collected
from 89 women at 32 to 34 weeks of pregnancy
and from 115 women at term. The sera were
separated and kept frozen at — 20 °C until
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further processing. Gestation period was calcu-
lated from the date of the last menstrual period
and confirmed by clinical examination. Patients
were excluded from the study for the following
reasons: uncertain gestation age, symptoms or
signs of threatened abortion, fetal death, sus-
pected twins, previous birth of a child with
neural-tube defect, maternal diabetes or hyper-
tension. All females attended the Antenatal
Clinic of the Newcastle General Hospital. Data
on smoking habit, parity and pregnancy num-
ber, newborn sex and 1 — minute Apgar score
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were obtained from the patients. Maternal
serum AFP was measured using radioimmuno-
assay kits (Hoechst-Behringwerke) and com-
puted from double determinations. Statistical
examination was carried out using the electron-
ic system SPSS [9]. Linear correlation coeffi-
cient of Pearson and analysis of variance (F,
Duncan new multiple range test) were em-
ployed. The level of significance was set at 5%.
3 Results
3.1 Relationship between AFP levels and
either parity or pregnancy number
No significant difference was observed between
maternal serum AFP mean levels of nullipa-
rous, women with one child or with two or more
children in the last two months of pregnancy,
although there was a slight suggestion that AFP
decreases as parity increases at 32 — 34 weeks
gestation (table I). Similar results were found
when pregnancy number was considered (table
II). When parity and pregnancy number were
correlated with AFP concentration in maternal
blood the coefficients of correlation were re-
spectively 0.002 (n = 89, P = 0.492) and
- 0.0184 (n = 89, P = 0.432) at 32-34 weeks
and - 0.0093 (n = 114, P = 0.461) and 0.0006
(n = 115, P = 0.498) at term.
3.2 Relation between AFP concentration and
1 — minute Apgar score
Table III shows that higher levels of AFP are
present in blood of mothers whose babies pre-
sented Apgar scores below 8, and this difference
became significant at 32—34 weeks gestation
or in the last two months of pregnancy (32—41
weeks). ;
.•|
3.3 Effect of smoking on maternal serum AFP
levels \
Table IV indicates that smokers have higher
AFP values than nonsmokers, particularly ΐ
Table I. Relation between parity and AFP concentrations (mean ± S.D.) at 32—34
weeks of pregnancy and at term.
Parity Concentration of AFP (ng/ml)
32-34wks
gestation
At term
Nulliparous
Parous (1 child)
Parous (2 or more children)
F Probability
235 ±96 (n = 36)
236±115(n = 29)
219 ±94 (n = 24)
0.7790
172±97(n = 57)
178 ± 93 (n = 39)
171 ± 71 (n = 18)
0.9478
Table Π. Relationship between pregnancy number and AFP levels (mean ± S.D.) at
32—34 weeks of pregnancy and at term.
Pregnancy number Concentration of AFP (ng/ml)
32-34wks
gestation
At term
One
Two
Three or more
F Probability
241 ± 100 (n = 30)
224 ± 107 (n = 28)
228 ±95 (n = 31)
0.8129
176 ± 102 (n = 48)
170 ±95 (n = 37)
172 ±71 (n = 30)
0.9654
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when they smoke more than 20 cigarettes per between nonsmokers and smokers of more than
day. It should be noted that the group of a pack per day in samples from 32 weeks to
nonsmokers corresponds to women who not term (P = 0.032).
only did not smoke during pregnancy but also
had never smoked at all. The overall statistical ~
 A T « - , A , , f
A.rr u . n - 3.4 Influence of newborn sex on the levels ofdifferences between all groups were however
 A17T> . . , . „ ..
. . .~ ,
 u , - Ji i.rr * AFP in maternal circulationnot significant; but, when the difference be-
tween the means of the various groups were Table V shows a clear tendency of higher AFP
computed separately, a significance appeared values in mothers of boys, and the difference
Table III. Comparison between AFP serum values (mean ± S.D.) of mothers whose babies had
Apgar scores equal or superior to 8 and below 8.
1-minute Apgar scores Maternal serum AFP concentration (ng/ml)
32 - 34 wks At term 32—41 wks
gestation gestation
Equal or above 8 217 ± 90 η = 67 168 ± 93 η = 82 190 ± 95 η = 149
Below 8 276 ± 115 η = 22 187 ± 87 η = 33 223 ± 107 n = 55
F Probability 0.014 0.294 0.032
Table IV. Maternal AFP levels (mean ± S.D.) of smokers and non-smokers in late pregnancy.
Maternal smoking habits Maternal serum concentration of AFP (ng/ml)
32—34 wks At term 32 wks of gestation
of gestation to term
Non-smokers 222 ±96 (n = 32) 170 ± 101 (n = 51) 190 ± 101 (n = 83)
Smokers,(up to 20 cigarettes per day) 247 ± 118 (n = 18) 165 ± 81 (n = 29) 196 ± 104 (n = 47)
Smokers (more than 20 cigarettes per day) 262 ± 114 (n = 10) 228 ± 114 (n = 12) 244 ± 113 (n = 22)
F Probability 0.507 0.135 0.096
Table V. Maternal serum AFP concentration in relation to the sex of the fetus in late
pregnancy.
Sex of fetus Maternal serum AFP concentration (ng/ml)
32—34 wks At term
of gestation
Males
Mean ± S.D. 251 ± 108 186 ± 95
n 45 60
Females
Mean ± S.D. 209 ± 87 161 ± 88
n 43 51
F Probability 0.044 0.153
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computed by analysis of variance became sig- placenta [1], similar to the ones encountered in
nificant when AFP reaches its peak in maternal diabetic angiopathy with increased microvascu-
blood (32-34 weeks gestation). lar permeability to plasma proteins [10], it is
feasible that the greater maternal blood AFP
values found by ourselves and by THOMSEN et
al. [13] reflects a leakage of the protein across
4 Discussion the placenta and/or through the membranes.
, ,, , . Therefore, since albumin is most like AFP in
AFP concentration in maternal blood is regu-
 molecular size and configuration, it is perfectly
lated by various and complex not yet fully
 understandable that albumin leakes in diabetics
understood mechanisms. Basically, it depends ^
 App does m nt smokers. In fact, since
on the rate of biosynthesis of the protein by
 maternal serum AFP is nearl totall derived
the fetal liver, its transference to maternal circu-
 from ^ fetug yia amniotic fluid and amniotic
lation and also on the rate of catabohsm. Any
 fluid albumin {s ^ ^ deriyed from matemal
factor which acts on these mechanisms would
 drculation in a proportional bidirectional pro-
certamly modify AFP values in maternal blood. ^
 movement it is ted that in ant
Hence, the present study investigated the
 smokers thereis also a leakage of albumin from
relationship between these values in the last
 mother,s Wood tQwards amniotic fluid This
two months of pregnancy and some obstetric
 represent an interesting field to study,landmarks such as parity, pregnancy number,
1 - minute Apgar score, smoking habit and
 Resuks of ^  nt stud algo confirm
newborn sex, in the hopes that some significant ^
 fmdm of ft correlatkm between hi h
association would elucidate the possible role of
 matemal senjm App leyds and fetal distress
Tf™ τ factorsuin controlling the levels [n n 15] We found ft iye association
of AFP. It was seen that parity and number of
 between maternal senjm App leyels and A
pregnancies do not correlate with the concen-
 SCQres Qf ^  newbo seemi that hi her
tration of AFP in maternal serum. Therefore,
 leyds Qf ^  in ^  nt m ^  blood Qf
these results do not indicate a general immuno-
 mothers who ^ ^ babieg f lower
suppressive role of AFP in late pregnancy in
 A Ξ«. * u . , , Λ
- ™ . . . * ι Γ j u Apgar scores. This can also be interpreted asthe maternal system, as postulated by some
 u , Γ , t , 1 U . · j- -+· + \H οι · Λ ι ^u 4.· · an altered fetal-maternal barrier, prejudicinginvestigators [7, 8], since the larger the antigenic n u · r Λ f * \ i*u ^ ΙιΛ ι ^-
,
6
,. ι
 A u * u r well-being of the fetus. Although this relation-stimulation provoked by a great number o f , - f ^ u -^ j r r i
• 4-u u- u 4-u ι ι r Λ ™ υ δ^Φ must not be considered as proof of a causalpregnancies the higher the levels of AFP would . . . ., , ^ ^ ,. „Γ 6 . . . j r . i - r ^ i · association, it m a y represent a potentially use-be expected in order to explain fetal nonrejec-
 r t , t . ', u . , . . ,* Λ. 4 . .^ ^ J ml tool to the obstetrician and pediatrician m
the management of a complicated pregnancy
The relationship between Apgar score, smoking and of the future newborn respectively,
habit and AFP concentration in maternal blood
gave rise to interesting findings. Our results Finally the degree of relationship between sex
suggest that serum AFP levels in late gestation of the newborn and the AFP levels was exam-
are elevated in heavy smokers compared to ined. Mothers of boys had significantly higher
nonsmokers, observations not yet reported ac- levels of the protein in their blood. These find-
cording to our knowledge. THOMSEN et al. [13] ings agree to some extent with those of CABAL-
have recently described an augmentation of LERO et al. [4] who, while using maternal blood
AFP levels in blood of pregnant smokers at 16 at delivery, found that mothers of boys contain-
weeks gestation. Therefore, it is possible that ed higher concentrations of AFP in their circu-
this elevation occurs throughout gestation, lation than did mothers of girls, although they
Since the habit of cigarette smoking provokes did not find significance in their analyses; this
important alterations in the ultrastructure of difference became significant when these inves-
the umbilical artery, umbilical vein and tigators studied serum AFP levels in newborn
J. Perinat. Med. 14 (1986)
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males and females (males contained greater
levels). In an effort to analyze the results of the
present study and those of CABALLERO et al.
[4], it may be postulated that male fetuses (hea-
vier than female fetuses) produce more AFP in
late pregnancy and this is reflected not only in
fetal circulation but in the mother's blood too.
It is also possible that some factors present in
males or females stimulate or inhibit respective-
ly AFP production and/or secretion. When
AFP level in maternal circulation is maximum
(32 — 34 weeks gestation), the sex variation is
more evident. Various hormones have been de-
scribed to suppress or encourage the protein
fabrication by the liver [5,14,16]. More investi-
gation in this area will probably uncover the
mechanisms responsible for the sex variation in
the AFP maternal serum values.
To the authors' knowledge some of the ap-
proaches examined in this study are original.
The results must be taken with caution. It is
advisable to extend the surveys performed to
all periods of gestation. The importance of the
screening test of AFP quantitation in pregnan-
cy serum for the prenatal diagnosis of malfor-
mations, particularly the open neural tube de-
fects, is well established at the present time and
largely used in developed countries. A correct
interpretation of this test may need special
tables of AFP normal ranges, which should
regard the factors briefly discussed above. Not
appreciating these elements could result in er-
roneous interpretation of the test result and
in turn lead to an aggressive plan for clinical
management which might include premature
and unjustified delivery.
Summary
Alpha-fetoprotein (AFP) quantitation in maternal blood
has been used for prenatal diagnosis of anencephaly,
spina bifida and some other congenital abnormalities.
The levels of AFP in pregnancy serum are greatly dis-
persed within each gestational period, what makes the
test of difficult interpretation mainly in border line cases.
The factors which contribute to this variability are still
poorly understood. They must act either on the synthesis
or catabolism of the protein, or on the permeability of
the fetal-maternal barrier. In an attempt to elucidate
some of these factors, the levels of AFP in serum of 89
women at 32 to 34 weeks gestation and of 115 women
at term were measured by radioimmunoassay and relat-
ed to several obstetric variables such as parity, pregnancy
number, 1 — minute Apgar score, smoking habit and
sex of newborn. It was seen that parity and pregnancy
number do not correlate with the levels of AFP in
pregnancy serum (tables I and II). Smokers, particularly
those who smoke more than a pack per day, however,
had higher levels of the protein in their blood (table
IV). The interpretation of these data should take into
consideration the fact that smoking causes vasoconstric-
tion and important vascular alterations similar to the
ones encountered in diabetic angiopathy. It is possible
that an increased microvascular permeability of placenta
and/or membranes to proteins of the size of AFP from
the fetus to maternal circulation may explain the greater
levels of the protein in serum of smokers. Higher AFP
levels were also found in blood of gravidas who gave
birth to babies with lower 1 — minute Apgar scores
(table III) what may be of interest to obstetric and
pediatric care as indicative of a high risk pregnancy with
a possibly feeble newborn. Finally we observed greater
levels of AFP in blood of mothers who gave birth
to male newborns (table V), what cannot be presently
explained. From the above mentioned results, it is con-
cluded that some of the variables described should be
taken into account when one analyzes AFP values in
maternal serum for prenatal diagnosis purposes.
Keywords: Alpha-fetoprotein, Apgar score, newborn, pregnancy serum, smoking.
Zusammenfassung
Beziehungen zwischen einigen geburtshilflichen Parame-
tern und der Alpha-Fetoproteinkonzentration im mütter-
lichen Blut
Die quantitative Bestimmung des Alpha-Fetoproteins
(AFP) im mütterlichen Serum dient der pränatalen Dia-
gnostik eines Anencephalus, einer Spina bifida und eini-
ger anderer kongenitaler Mißbildungen. Während der
einzelnen Gestationsabschnitte zeigt der AFP-Spiegel
eine große Streubreite, was die Interpretation der Werte,
besonders in Grenzfällen, erschwert. Über die Ursachen
dieser Variabilität ist bisher wenig bekannt. Möglicher-
weise sind die Synthese und der Katabolismus des Pro-
J. Perinat. Med. 14 (1986)
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teins oder die Permeabilität der feto-maternalen Schran-
ke daran beteiligt. Zur Abklärung einiger Faktoren wur-
de der AFP-Spiegel im Serum von 89 Frauen in der 32.
bis 34. Schwangerschaftswoche sowie von 115 Frauen
am Termin über einen Radioimmunassay bestimmt und
dann zu verschiedenen geburtshilflichen Parametern wie
Parität, Anzahl der Schwangerschaften, Apgar-Score
nach l Minute, Rauchgewohnheiten und Geschlecht des
Neugeborenen in Beziehung gesetzt. Wir konnten zeigen,
daß zwischen der Parität sowie der Anzahl der Gravidi-
täten und dem mütterlichen AFP-Spiegel keine Korrela-
tion besteht (Tabellen I und II). Raucherinnen, beson-
ders solche mit mehr als 20 Zigaretten pro Tag, hatten
höhere AFP-Spiegel im Serum (Tabelle IV). Hier gilt es
zu berücksichtigen, daß das Rauchen eine Vasokonstrik-
tion sowie Veränderungen an den Blutgefäßen verur-
sacht, vergleichbar den Veränderungen bei einer diabeti-
schen Angiopathie. Denkbar ist eine erhöhte Permea-
bilität von Mikrogefaßen der Plazenta für Proteine von
der Größe des AFP. Höhere AFP-Spiegel wurden auch
im Blut von Schwangeren gefunden, deren Neugeborene
einen niedrigen Apgar-Score l Minute p. p. aufwiesen
(Tabelle III). So könnte ein höherer AFP-Spiegel als
Hinweis für eine Risikoschwangerschaft sowie ein mögli-
cherweise deprimiertes Kind gewertet werden. Schließ-
lich konnten wir beobachten, daß die AFP-Spiegel bei
Müttern von männlichen Neugeborenen höher waren,
ohne daß wir eine Erklärung dafür finden konnten (Ta-
belle V). Wir meinen, daß einige der oben beschriebenen
Parameter berücksichtigt werden sollten, wenn AFP-
Bestimmungen zum Zweck der pränatalen Diagnostik
durchgeführt werden.
Schlüsselwörter: Alpha-Fetoprotein, Apgar-Score, Neugeborenes, Rauchen, Serum bei Schwangeren.
Resume
Relations entre quelques parametres obstetricaux et la
concentration maternelle sanguine d'alphafcetoproteine
Le dosage de Falpha-fcetoproteine (AFP) dans le serum
des femmes enceintes a ete employe pour le diagnostic
prenatal d'anencephalie de spina bifida et d'autres ano-
malies congenitales. Les taux d'alpha-foetoproteine dans
le serum des femmes enceintes sont tres disperses ä
chaque periode de la grossesse ce qui rend difficile Pinter-
pretation du test, surtout pour les dosages limites. Les
facteurs qui contribuent ä cette variabilite sont encore
mal compris. II peuvent agir aussi bien sur la Synthese
que sur le catabolisme des proteines, ou sur la permeabi-
lite de la barriere materno-foetale. Pour en elucider
quelques-uns, les taux d'AFP serique de 89 femmes de
32 ä 34 semaines de gestation et de 115 femmes ä terme,
ont ete mesures par radioimunoessai et correlationnes
avec quelques variables obstetricales (parite, numero de
gestations, tabagisme, score d'apgar ä la lere minute,
poids du nouveau-ne et du placenta et sexe du nouveau-
ne). Les correlations ont ete calculees parmi quelques
parametres obstetricaux.
Parite et numero de gestations ne sont pas correles
avec le taux d'AFP dans le serum des femmes enceintes
(tableaux I et II). Les fumeuses, particulierement celles
qui fumaient plus d'un paquet par jour, cependant, ont
eu les taux d'AFP les plus eleves (tableau IV). L'interpre-
tation de ces donnees doit faire considerer le fait que
fumer cause une vasoconstriction et d'autres importantes
alterations vasculaires semblables ä celles trouvees dans
Pangiopathie diabetique. II est possible, done, qu'une
permeabilite microvasculaire augmentee, du placenta et/
ou des membranes pour les proteines de la taille de
l'AFP, du foetus vers la circulation maternelle puisse
expliquer les niveaux assez eleves d'AFP dans le serum
des fumeuses. Les niveaux les plus eleves d'AFP ont ete
observes dans le serum des meres dont les nouveaux-nes
avaient les scores d'apgar (tableau III) les plus bas ce
qui peut etre interessant pourjes soints obstetricaux et
pediatriques comme indicatifs de grossesse ä haut risque
et de la possibilite d'un nouveau-ne faible.
Finalement, nous avons observe les taux les plus eleves
d'AFP dans le serum des meres dont les nouveaux-nes
etaient de sexe masculin, ce qui ne peut pas encore
etre explique (tableau V). Les resultats presentes ici
permettent de conclure que quelques-unes de ces varia-
bles decrites doivent etre considerees quand on analyse
les serum des femmes enceintes pour le diagnostic prena-
tal.
Mots-cles: Alpha-foetoproteine, fumeuses, nouveau-ne, scores d'Apgar, serum des femmes enceintes.
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